Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | huMNC2-CAR44 CAR T cells |
Synonyms | |
Therapy Description |
huMNC2-CAR44 CAR T cells are T-cells that have been engineered to express a chimeric antigen receptor (CAR) that targets a cleaved version of MUC1 (MUC1*), which may increase immune response against MUC1*-expressing tumor cells and decrease tumor growth (Cytotherapy, Volume 20, Issue 5, S7). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
huMNC2-CAR44 CAR T cells | huMNC2-CAR44 CAR T cells are T-cells that have been engineered to express a chimeric antigen receptor (CAR) that targets a cleaved version of MUC1 (MUC1*), which may increase immune response against MUC1*-expressing tumor cells and decrease tumor growth (Cytotherapy, Volume 20, Issue 5, S7). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04020575 | Phase I | huMNC2-CAR44 CAR T cells | Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) | Recruiting | USA | 0 |